M Santonocito
Overview
Explore the profile of M Santonocito including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mangiafico R, Malatino L, Spada R, Santonocito M, Messina R, DellArte S, et al.
Int Angiol
. 2000 Jun;
19(1):14-7.
PMID: 10853680
Background: Endothelin-1 (ET-1) is an endothelial vasoconstrictor mitogenic peptide which is thought to be a marker of endothelial damage and a potential participant in the pathophysiological processes of the development...
2.
Mangiafico R, Malatino L, Santonocito M, Messina R, Attina T, DellArte S, et al.
Int J Clin Pharmacol Ther
. 1999 Aug;
37(7):347-51.
PMID: 10442509
Objective: Endothelin-1 (ET-1) is a vasoconstrictor mitogenic peptide whose plasma concentrations are increased in patients with peripheral arterial occlusive disease (PAOD). The aim of this study was to investigate whether...
3.
Mangiafico R, Malatino L, Santonocito M, Sarnataro F, DellArte S, Messina R, et al.
Panminerva Med
. 1999 May;
41(1):22-6.
PMID: 10230252
Unlabelled: Endothelin-1 (ET-1) is a potent vasoconstrictor and mitogenic peptide produced and secreted by endothelial cells, which can play a potential role in the development of atherosclerosis and in the...
4.
Mangiafico R, Spada R, Messina R, Attina T, Santonocito M, DellArte S
Minerva Cardioangiol
. 1999 Feb;
46(9):347-8.
PMID: 10021875
No abstract available.
5.
Spada R, Ferri R, Mangiafico R, Roccasalva G, Toscano G, Di Cataldo V, et al.
Minerva Cardioangiol
. 1999 Feb;
46(9):306-7.
PMID: 10021855
No abstract available.
6.
Mangiafico R, Malatino L, Santonocito M, Spada R
Int Angiol
. 1998 Oct;
17(2):97-102.
PMID: 9754897
Background: Endothelin-1 (ET-1), a vasoconstrictor and mitogenic endothelium-derived peptide, has been considered as a marker for endothelial damage and potential contributor to the development of the atherogenic process. Methods: To...
7.
Mangiafico R, Malatino L, Santonocito M, Spada R, Benedetto F
Angiology
. 1997 Oct;
48(9):769-74.
PMID: 9313626
The aim of the study was to investigate the release of endothelin-1 (ET-1) in normal and varicose saphenous veins at baseline and after venous stasis test. Ten patients (eight women...
8.
Mangiafico R, Malatino L, Spada R, Santonocito M
Panminerva Med
. 1996 Dec;
38(4):229-33.
PMID: 9063031
The present study was designed to examine the role of endothelin-1 (ET-1), an endothelium-derived potent long-acting vasoconstrictor peptide, in vascular acrosyndromes with hypersensitivity to cold. Plasma ET-1 concentration was measured,...
9.
Mangiafico R, Malatino L, Santonocito M, Spada R, TAMBURINO G
Angiology
. 1996 Nov;
47(11):1033-8.
PMID: 8921751
To assess endothelin-1 (ET-1) response to cold stimulation in essential acrocyanosis (EA), the authors measured ET-1 plasma concentrations in 6 patients with EA (6 women, age range seventeen to thirty-seven...
10.
Mangiafico R, Malatino L, Santonocito M, Spada R, Polizzi G, TAMBURINO G
Int Angiol
. 1996 Sep;
15(3):240-4.
PMID: 8971583
The present study was designed to investigate the pattern of circulating endothelin-1 (ET-1), a potent vasoconstricting mitogenic endothelium-derived peptide, in relation to primary increase in serum cholesterol in humans. We...